Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Prenatal Exposure to Acetaminophen and the Risk of Attention-Deficit/Hyperactivity Disorder: A Nationwide Study in Taiwan.

Chen MH, Pan TL, Wang PW, Hsu JW, Huang KL, Su TP, Li CT, Lin WC, Tsai SJ, Chen TJ, Bai YM.

J Clin Psychiatry. 2019 Sep 10;80(5). pii: 18m12612. doi: 10.4088/JCP.18m12612.

PMID:
31509360
2.

Association Between Prenatal Acetaminophen Exposure and Future Risk of Attention Deficit/Hyperactivity Disorder in Children.

Hoover RM, Hayes VA, Erramouspe J.

Ann Pharmacother. 2015 Dec;49(12):1357-61. doi: 10.1177/1060028015606469. Epub 2015 Sep 23. Review.

PMID:
26400006
3.

Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.

Sujan AC, Rickert ME, Öberg AS, Quinn PD, Hernández-Díaz S, Almqvist C, Lichtenstein P, Larsson H, D'Onofrio BM.

JAMA. 2017 Apr 18;317(15):1553-1562. doi: 10.1001/jama.2017.3413.

4.

Association of maternal prenatal acetaminophen use with the risk of attention deficit/hyperactivity disorder in offspring: A meta-analysis.

Gou X, Wang Y, Tang Y, Qu Y, Tang J, Shi J, Xiao D, Mu D.

Aust N Z J Psychiatry. 2019 Mar;53(3):195-206. doi: 10.1177/0004867418823276. Epub 2019 Jan 17.

PMID:
30654621
5.

Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders.

Liew Z, Ritz B, Rebordosa C, Lee PC, Olsen J.

JAMA Pediatr. 2014 Apr;168(4):313-20. doi: 10.1001/jamapediatrics.2013.4914.

PMID:
24566677
6.

Maternal Polycystic Ovary Syndrome and Risk for Attention-Deficit/Hyperactivity Disorder in the Offspring.

Kosidou K, Dalman C, Widman L, Arver S, Lee BK, Magnusson C, Gardner RM.

Biol Psychiatry. 2017 Nov 1;82(9):651-659. doi: 10.1016/j.biopsych.2016.09.022. Epub 2016 Oct 6.

7.

Maternal smoking during pregnancy and offspring attention-deficit/hyperactivity disorder: a case-control study in Japan.

Yoshimasu K, Kiyohara C, Minami T, Yoshikawa N, Kihira S, Toyonaga K, Yamamoto A, Shinosaki K, Yamashita H, Miyashita K; Wakayama ADHD Study Group.

Atten Defic Hyperact Disord. 2009 Dec;1(2):223-31. doi: 10.1007/s12402-009-0015-1. Epub 2009 Nov 12.

PMID:
21432585
8.

Maternal Biomarkers of Acetaminophen Use and Offspring Attention Deficit Hyperactivity Disorder.

Ji Y, Riley AW, Lee LC, Hong X, Wang G, Tsai HJ, Mueller NT, Pearson C, Thermitus J, Panjwani A, Ji H, Bartell TR, Burd I, Fallin MD, Wang X.

Brain Sci. 2018 Jul 3;8(7). pii: E127. doi: 10.3390/brainsci8070127.

9.

Prenatal Exposure to Acetaminophen and Risk of ADHD.

Ystrom E, Gustavson K, Brandlistuen RE, Knudsen GP, Magnus P, Susser E, Davey Smith G, Stoltenberg C, Surén P, Håberg SE, Hornig M, Lipkin WI, Nordeng H, Reichborn-Kjennerud T.

Pediatrics. 2017 Nov;140(5). pii: e20163840. doi: 10.1542/peds.2016-3840.

10.

Attention-Deficit/Hyperactivity Disorder in Offspring of Mothers With Inflammatory and Immune System Diseases.

Instanes JT, Halmøy A, Engeland A, Haavik J, Furu K, Klungsøyr K.

Biol Psychiatry. 2017 Mar 1;81(5):452-459. doi: 10.1016/j.biopsych.2015.11.024. Epub 2015 Dec 9.

11.

Association of Maternal Exposure to Childhood Abuse With Elevated Risk for Attention Deficit Hyperactivity Disorder in Offspring.

Roberts AL, Liew Z, Lyall K, Ascherio A, Weisskopf MG.

Am J Epidemiol. 2018 Sep 1;187(9):1896-1906. doi: 10.1093/aje/kwy098.

12.

Parental age and the risk of attention-deficit/hyperactivity disorder: a nationwide, population-based cohort study.

Chudal R, Joelsson P, Gyllenberg D, Lehti V, Leivonen S, Hinkka-Yli-Salomäki S, Gissler M, Sourander A.

J Am Acad Child Adolesc Psychiatry. 2015 Jun;54(6):487-94.e1. doi: 10.1016/j.jaac.2015.03.013. Epub 2015 Mar 27.

PMID:
26004664
13.

Maternal serum C-reactive protein (CRP) and offspring attention deficit hyperactivity disorder (ADHD).

Chudal R, Brown AS, Gyllenberg D, Hinkka-Yli-Salomäki S, Sucksdorff M, Surcel HM, Upadhyaya S, Sourander A.

Eur Child Adolesc Psychiatry. 2019 Jul 16. doi: 10.1007/s00787-019-01372-y. [Epub ahead of print]

PMID:
31312974
14.

Maternal fever during pregnancy and offspring attention deficit hyperactivity disorder.

Gustavson K, Ask H, Ystrom E, Stoltenberg C, Lipkin WI, Surén P, Håberg SE, Magnus P, Knudsen GP, Eilertsen E, Bresnahan M, Aase H, Mjaaland S, Susser ES, Hornig M, Reichborn-Kjennerud T.

Sci Rep. 2019 Jul 2;9(1):9519. doi: 10.1038/s41598-019-45920-7.

15.

Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder.

Pringsheim T, Sandor P, Lang A, Shah P, O'Connor P.

J Dev Behav Pediatr. 2009 Apr;30(2):115-21. doi: 10.1097/DBP.0b013e31819e6a33.

PMID:
19322105
16.

Use of Negative Control Exposure Analysis to Evaluate Confounding: An Example of Acetaminophen Exposure and Attention-Deficit/Hyperactivity Disorder in Nurses' Health Study II.

Liew Z, Kioumourtzoglou MA, Roberts AL, O'Reilly ÉJ, Ascherio A, Weisskopf MG.

Am J Epidemiol. 2019 Apr 1;188(4):768-775. doi: 10.1093/aje/kwy288.

PMID:
30923825
17.
18.

Association of Maternal Neurodevelopmental Risk Alleles With Early-Life Exposures.

Leppert B, Havdahl A, Riglin L, Jones HJ, Zheng J, Davey Smith G, Tilling K, Thapar A, Reichborn-Kjennerud T, Stergiakouli E.

JAMA Psychiatry. 2019 May 1. doi: 10.1001/jamapsychiatry.2019.0774. [Epub ahead of print]

19.
20.

Late-pregnancy dysglycemia in obese pregnancies after negative testing for gestational diabetes and risk of future childhood overweight: An interim analysis from a longitudinal mother-child cohort study.

Gomes D, von Kries R, Delius M, Mansmann U, Nast M, Stubert M, Langhammer L, Haas NA, Netz H, Obermeier V, Kuhle S, Holdt LM, Teupser D, Hasbargen U, Roscher AA, Ensenauer R.

PLoS Med. 2018 Oct 29;15(10):e1002681. doi: 10.1371/journal.pmed.1002681. eCollection 2018 Oct.

Supplemental Content

Support Center